BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 20635476)

  • 1. Preparation and evaluation of fexofenadine microemulsions for intranasal delivery.
    Piao HM; Balakrishnan P; Cho HJ; Kim H; Kim YS; Chung SJ; Shim CK; Kim DD
    Int J Pharm; 2010 Aug; 395(1-2):309-16. PubMed ID: 20635476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and evaluation of fexofenadine microemulsion for intranasal delivery.
    Piao HM; Balakrishnan P; Cho HJ; Kim H; Kim YS; Chung SJ; Shim CK; Kim DD
    Int J Pharm; 2010 Jun; ():. PubMed ID: 20685383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of cosurfactants and oils on the formation of pharmaceutical microemulsions based on PEG-8 caprylic/capric glycerides.
    Djekic L; Primorac M
    Int J Pharm; 2008 Mar; 352(1-2):231-9. PubMed ID: 18068919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of udenafil-loaded microemulsions for intranasal delivery: in vitro and in vivo evaluations.
    Cho HJ; Ku WS; Termsarasab U; Yoon I; Chung CW; Moon HT; Kim DD
    Int J Pharm; 2012 Feb; 423(2):153-60. PubMed ID: 22209996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced systemic exposure of fexofenadine via the intranasal administration of chitosan-coated liposome.
    Qiang F; Shin HJ; Lee BJ; Han HK
    Int J Pharm; 2012 Jul; 430(1-2):161-6. PubMed ID: 22525082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of water-in-oil microemulsion for oral delivery of earthworm fibrinolytic enzyme.
    Cheng MB; Wang JC; Li YH; Liu XY; Zhang X; Chen DW; Zhou SF; Zhang Q
    J Control Release; 2008 Jul; 129(1):41-8. PubMed ID: 18474405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of surfactant/cosurfactant synergism impact on ibuprofen solubilization capacity and drug release characteristics of nonionic microemulsions.
    Djekic L; Primorac M; Filipic S; Agbaba D
    Int J Pharm; 2012 Aug; 433(1-2):25-33. PubMed ID: 22579578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems.
    Balakrishnan P; Lee BJ; Oh DH; Kim JO; Lee YI; Kim DD; Jee JP; Lee YB; Woo JS; Yong CS; Choi HG
    Int J Pharm; 2009 Jun; 374(1-2):66-72. PubMed ID: 19446761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation.
    Yin YM; Cui FD; Mu CF; Choi MK; Kim JS; Chung SJ; Shim CK; Kim DD
    J Control Release; 2009 Dec; 140(2):86-94. PubMed ID: 19709639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation development and bioavailability evaluation of a self-nanoemulsified drug delivery system of oleanolic acid.
    Xi J; Chang Q; Chan CK; Meng ZY; Wang GN; Sun JB; Wang YT; Tong HH; Zheng Y
    AAPS PharmSciTech; 2009; 10(1):172-82. PubMed ID: 19224372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation, evaluation, and NMR characterization of vinpocetine microemulsion for transdermal delivery.
    Hua L; Weisan P; Jiayu L; Ying Z
    Drug Dev Ind Pharm; 2004 Jul; 30(6):657-66. PubMed ID: 15285339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and development of microemulsion drug delivery system of acyclovir for improvement of oral bioavailability.
    Ghosh PK; Majithiya RJ; Umrethia ML; Murthy RS
    AAPS PharmSciTech; 2006 Sep; 7(3):77. PubMed ID: 17025257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation on the targeting efficiency to the brain.
    Zhang Q; Jiang X; Jiang W; Lu W; Su L; Shi Z
    Int J Pharm; 2004 May; 275(1-2):85-96. PubMed ID: 15081140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an ethyl laurate-based microemulsion for rapid-onset intranasal delivery of diazepam.
    Li L; Nandi I; Kim KH
    Int J Pharm; 2002 Apr; 237(1-2):77-85. PubMed ID: 11955806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid spray formulations of xibornol by using self-microemulsifying drug delivery systems.
    Cirri M; Mura P; Mora PC
    Int J Pharm; 2007 Aug; 340(1-2):84-91. PubMed ID: 17531411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation of microemulsion systems for dermal delivery of silymarin.
    Panapisal V; Charoensri S; Tantituvanont A
    AAPS PharmSciTech; 2012 Jun; 13(2):389-99. PubMed ID: 22350738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The application of artificial neural networks in the prediction of microemulsion phase boundaries in PEG-8 caprylic/capric glycerides based systems.
    Djekic L; Ibric S; Primorac M
    Int J Pharm; 2008 Sep; 361(1-2):41-6. PubMed ID: 18571348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of effect of water-in-oil microemulsion as an oral delivery system for fexofenadine: in vitro and in vivo studies.
    Gundogdu E; Alvarez IG; Karasulu E
    Int J Nanomedicine; 2011; 6():1631-40. PubMed ID: 21904453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic delivery of insulin via the nasal route using a new microemulsion system: In vitro and in vivo studies.
    Sintov AC; Levy HV; Botner S
    J Control Release; 2010 Dec; 148(2):168-76. PubMed ID: 20709120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intestinal first-pass hydrolysis on the oral bioavailability of an ester prodrug of fexofenadine.
    Ohura K; Soejima T; Nogata R; Adachi Y; Ninomiya S; Imai T
    J Pharm Sci; 2012 Sep; 101(9):3264-74. PubMed ID: 22628163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.